Plegridy and Humalog drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Plegridy (peginterferon beta-1a) and Humalog (insulin lispro recombinant). Common drug interactions include fatigue among females and cerebral haemorrhage among males.

The phase IV clinical study analyzes what interactions people have when they take Plegridy and Humalog. It is created by eHealthMe based on reports of 17 people who take the same drugs from the FDA, and is updated regularly.

What is Plegridy?

Plegridy has active ingredients of peginterferon beta-1a. eHealthMe is studying from 14,764 Plegridy users. Check the latest studies of Plegridy.

What is Humalog?

Humalog has active ingredients of insulin lispro recombinant. It is often used in diabetes. eHealthMe is studying from 137,127 Humalog users. Check the latest studies of Humalog.



On Jul, 17, 2026

17 people who take Plegridy and Humalog together, and have interactions are studied.

Plegridy and Humalog drug interactions.

What are the common drug interactions of Plegridy and Humalog, by gender? *:

female:

  1. Fatigue (feeling of tiredness)
  2. Dizziness
  3. Dry skin
  4. Dysphagia (a condition in which swallowing is difficult or painful)
  5. Emotional disorder
  6. Injection site dryness
  7. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  8. Tremor (trembling or shaking movements in one or more parts of your body)
  9. Anxiety
  10. Apathy

male:

  1. Cerebral haemorrhage (bleeding within the brain)
  2. Asthenia (weakness)
  3. Gait disturbance
  4. Hypoaesthesia (reduced sense of touch or sensation)
  5. Limb discomfort (discomfort in leg)
  6. Muscular weakness (muscle weakness)
  7. Chills (felling of cold)
  8. Gastric ulcer (stomach ulcer)
  9. Gastrointestinal inflammation (inflammation of stomach and intestine)
  10. Influenza like illness

What are the common drug interactions of Plegridy and Humalog, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Dizziness
  2. Dry skin
  3. Dysphagia (a condition in which swallowing is difficult or painful)
  4. Emotional disorder
  5. Fatigue (feeling of tiredness)
  6. Injection site dryness
  7. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  8. Tremor (trembling or shaking movements in one or more parts of your body)
  9. Contusion (a type of hematoma of tissue in which capillaries)
  10. Injection site bruising

50-59:

  1. Chills (felling of cold)
  2. Gastric ulcer (stomach ulcer)
  3. Gastrointestinal inflammation (inflammation of stomach and intestine)
  4. Influenza like illness
  5. Oesophageal stenosis (narrowing of oesophagus)
  6. Small intestinal obstruction (blockage in small intestine)
  7. Anxiety
  8. Apathy
  9. Chest discomfort
  10. Chest pain

60+:

  1. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  2. Coronary artery bypass

What are the existing conditions these people have? *

  1. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 15 people, 88.24%
  2. Gait Disturbance: 4 people, 23.53%
  3. Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 1 person, 5.88%
  4. Hepatitis C: 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Plegridy and Humalog?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Plegridy and Humalog:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Plegridy:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Humalog:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Plegridy and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Humalog and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on peginterferon beta-1a and insulin lispro recombinant (the active ingredients of Plegridy and Humalog, respectively), and Plegridy and Humalog (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: